
Login
Related Links
Advertise on this site?
Advertising opportunities on Gene Therapy Net include standard size banners as well as text ads. Click here for more information about advertising.
You can also make a donation by PayPal and support the Gene Therapy Net website.
Companies - A
Addgene Non-profit organization working with hundreds of laboratories to assemble a high-quality library of published plasmids for use in research and discovery. By linking plasmids with articles, scientists can always find data related to the materials they request. |
|
Advanced Cell & Gene Therapy, LLC Consulting firm in cell therapy, gene therapy and tissue therapies, serving biotechnology companies, clinical laboratories, and biotechnology investors. |
|
Advanced Vision Therapies, Inc. Gene transfer technology for the treatment of eye diseases like Wet Age-Related Macular Degeneration (AMD), Diabetic Proliferative Retinopathy (DPR), Retinitis Pigmentosa (RP) and Dry Age-Related Macular Degeneration. |
|
AlphaVax Human Vaccines, Inc. AlphaVax is developing a new vaccine technology, alphavaccines, with broad applications against cancer and infectious disease, like pandemic influenza and cytomegalovirus. |
|
Altogen Biosystems Life sciences company dedicated to the development, marketing and manufacture of cell line specific transfection reagents for intracellular delivery of biomolecules (siRNA and plasmid DNA). |
|
American Gene Technologies Gene and cell therapeutics company with a proprietary lentiviral platform capable of broad applications. The company expects its lead candidate for an HIV cure to enter the clinic in 2018, and it has developed a patented immuno-oncology approach to attack a variety of epithelial cancers that is expected to enter trials soon. |
|
Applied Tissue Technologies LLC Technologies focus on direct methods of treating infection in skin wounds, transplanting skin to wounds, and delivering genes to skin cells. |
|
Ark Therapeutics Ltd. Gene therapy company focuses on areas of high unmet clinical need in vascular disease, wound care and cancer. Products in late stage clinical development: Cerepro®, Vitor™ and Trinam® |
|
Arthrogen An Amsterdam based clinical stage, biopharmaceutical company, is developing local gene therapy for inflammatory diseases, using viral mediated gene transfer. The first target indication is in the field of rheumatic diseases. Currently two phase Ib trials are ongoing, one in Canada and one in the Netherlands. |
|
Asklepios BioPharmaceutical Inc. Biotechnology company engaged in the development and delivery of novel protein and cellular based therapies through design of Biological Nano Particles (BNP). BNPs are synthetically designed from components of different Adeno Associated Viruses as well as other parvoviruses. |
|
Athersys, Inc. Clinical stage biopharmaceutical company with lead programs in the areas of obesity, cardiovascular disease (myocardial infarction), and bone marrow transplant support. |
|
Austrianova Focused on the development and manufacture of highly innovative tumour treatments based on localized cell therapies. Reference product NovaCaps® is the first encapsulated cell product targeting solid tumours. |
|
Information Companies
Overview of biotechnology companies involved in gene therapy and/or cell therapy, as well as contract research organizations (CRO) and medical supply companies.
The provided information about the companies is just a summary of the information giving on their websites and is therefore not always complete, correct and/or exhaustive. Please visit the companies websites for a complete picture of the company.
Your company not listed? Click here to submit.
Like to work for a company? Find here the perfect job in gene therapy.
Gene Therapy News
- Study finds method of delivering clinically used gene therapy vectors - ANI News
Sun, 01 Oct 2023 14:03:0 GMT - Florida Nemours Children’s Hospital treats first patient with gene therapy - WFTV Orlando
Sat, 30 Sep 2023 22:23:4 GMT - New “multipronged” gene therapy reverses paralysis in mice - Freethink
Sat, 30 Sep 2023 17:00:0 GMT - The Framework for Embracing Gene Therapy in Hemophilia Treatment - AJMC.com Managed Markets Network
Sat, 30 Sep 2023 15:34:5 GMT - Gene therapy startup Lexeo, inflammatory biotech Abivax submit ... - Endpoints News
Fri, 29 Sep 2023 22:44:0 GMT - UCI named one of CIRM’s cell and gene therapy manufacturing ... - UCI Health
Fri, 29 Sep 2023 17:57:3 GMT - Best Research Report on Cell and Gene Therapy Production Services Market by Forecast to 2030 With Covered Top - openPR
Fri, 29 Sep 2023 14:55:0 GMT - Insights Into the Gene Therapy CDMO Services Market Trends, Size, Share, and Future Growth up to 2030 for Appl - openPR
Fri, 29 Sep 2023 14:31:0 GMT - Ocugen CSO to Participate in 4th Annual Gene Therapy for Ophthalmic Disorders Conference - Ocugen
Fri, 29 Sep 2023 13:32:5 GMT - Nanoscope Therapeutics to Present at the 4th Annual Gene Therapy ... - PR Newswire
Thu, 28 Sep 2023 22:15:0 GMT - Advancement of potential gene therapy could offer new hope for ... - News-Medical.Net
Thu, 28 Sep 2023 18:58:0 GMT - 'We've hit the nadir': Penn's Dr. James Wilson sees brighter days ahead for cell and gene therapy - The Business Journals
Thu, 28 Sep 2023 17:59:0 GMT - Global Next Generation Sequencing (NGS) Informatics Market Research Report 2023-2030: NGS Revolutionizes Drug Discovery with Targeted Therapies and Gene Therapy - Yahoo Finance
Thu, 28 Sep 2023 10:18:0 GMT - Study points to new risk in gene therapy death of Terry Horgan - STAT
Wed, 27 Sep 2023 23:03:1 GMT - Death after High-Dose rAAV9 Gene Therapy in a Patient with ... - nejm.org
Wed, 27 Sep 2023 23:03:1 GMT